Menstrual blood loss in women using the frameless FibroPlant® LNG-IUS

Contraception

Volumn 79, Issue 2, 2009, Pages 134-138

  Andrade, Amaury ^a   Wildemeersch, Dirk ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Gynecological Outpatient Clinic and IUD Training Center   (Belgium)

Author keywords

Contraception; Frameless intrauterine system; Heavy menstrual bleeding; Levonorgestrel (LNG); Menstrual blood loss

Indexed keywords

FERRITIN; HEMATIN; LEVONORGESTREL;

AMENORRHEA; ARTICLE; BLEEDING; BRAZIL; CONTRACEPTION; CONTRACEPTIVE DEVICE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HUMAN; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; MENSTRUAL BLOOD LOSS; PREGNANCY; PROSPECTIVE STUDY; QUANTITATIVE STUDY;

ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENORRHAGIA; MENSTRUATION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58149170592     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.09.007     Document Type: Article

References (27)

1. Hasson H.M. Clinical studies of the Wing Sound II metrology device. In: Zatuchni G.I., Goldsmith A., and Sciarra J.J. (Eds). Intrauterine contraception: advances and future prospects (1984), Harper & Row, Philadelphia 126-141
2. Kurz K.H. Cavimeter uterine measurements and IUD clinical correlation. In: Zatuchni G.I., Goldsmith A., and Sciarra J.J. (Eds). Intrauterine contraception: advances and future prospects (1984), Harper & Row, Philadelphia 142-162
3. Wildemeersch D., Pylyser K., De Wever N., and Dhont M. Treatment of non atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up. Maturitas 57 (2007) 210-213
4. Wildemeersch D., and Rowe P.J. Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system. Contraception 70 (2004) 165-168
5. Edlund M., Magnusson C., and Von Schoultz B. Quality of life - a Swedish survey of 2200 women. Key Paper Conf (published by the Royal Society of Medicine Press Limited) 1 (1994) 36-37
6. Coulter A., Bradlow J., and Agass M. Outcomes of referrals to gynecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynecol 98 (1991) 789-796
7. Clarke A., Black N., Rowe P., Mott S., and Howie K. Indications for and outcomes of total abdominal hysterectomy for benign disease: a prospective cohort study. Br J Obstet Gynecol 102 (1995) 611-620
8. Cameron I.T., and Smith S.K. Menorrhagia. In: Greer I., Turpie A., and Forbes C. (Eds). Haemostasis and thrombosis in obstetrics and gynecology (1992), Associated Books, London 77-93
9. World Health Organization (WHO). Medical eligibility criteria for contraceptive use (2000), WHO, Geneva, Switzerland
10. Hallberg L., and Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 16 (1964) 244-248
11. Shaw Jr. S.T. On quantifying menstrual blood loss. Contraception 16 (1977) 283-285
12. Newton J., Barnard G., and Collins W. A rapid method for measuring menstrual blood loss using automatic extraction. Contraception 16 (1977) 269-282
13. Andrade A.T.L., Souza J.P., Shaw Jr. S.T., Belsey E.M., and Rowe P.J. Menstrual blood loss and body iron stores in Brazilian women. Contraception 43 (1991) 241-249
14. Guttinger A., and Critchley H.O.D. Endometrial effects of intrauterine levonorgestrel. Contraception 75 (2007) S93-S98
15. Wildemeersch D. The force required to remove the frameless 0-suture anchoring system: comparison between pre- and postmenopausal women. Contraception 69 (2004) 513-515
16. India Council of Medical Research Task Force on IUD. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), Cu T 380Ag, Cu T 220C and Cu T 200B. A 36-month study. Contraception 39 (1989) 169-179
17. Allonen H. The Levonorgestrel IUD. In: Bardin C.W.B., and Mishell Jr. D.R. (Eds). A new look at IUDs - Advancing contraceptive choices. Fourth Conference on IUDs (1992), Butterwords-Heinemann, Boston 284-292
18. Wildemeersch D., and Schacht E. The effect on menstrual blood loss in women with uterine fibroids of a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system, a pilot study. Eur Obstet Gynecol Reprod Biol 102 (2002) 74-79
19. Magalhães J., Aldrighi J.M., and de Lima G.R. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception. 7 (2007) 193-198
20. Rizkalla H.F., Higgins M., Kelehan P., and O'Herlihy C. Pathological findings associated with the presence of a Mirena intrauterine system at hysterectomy. Int J Gynecol Pathol. 27 (2008) 74-78
21. Wood C. Menorrhagia: a management update. Mod Med Australia 42 (1999) 65-75
22. National Institute for Health and Clinical Excellence (NICE). Heavy menstrual bleeding. Published by the RCOG Press at the Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent's Park, London NW1 4RG (http://www.rcog.org.uk).
23. Hurskainen R. Managing drug-resistant essential menorrhagia without hysterectomy. Best Pract Res Clin Obstet Gynecol 20 (2006) 681-694
24. Bahamondes L., Petta C.A., Fernandes A., and Monteiro I. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrheal. Contraception 75 (2007) S134-S139
25. Fedele L., Bianci S., Raffaelli R., Portuese A., and Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 68 (1997) 426-429
26. Boudrez P., Bongers M.Y., and Mol B.W.J. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Fertil Steril 82 (2004) 160-166
27. Maia Jr. H., Maltez A., Coelho G., Athayde C., and Coutinho E.M. Insertion of Mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 10 (2003) 512-516